Return to Trial Database

HCRN-LUN02-29

A Phase II Trial of ZD1839 (IRESSA®) in Both Patients with Chemosensitive and Chemorefractory Relapsed Neuroendocrine Cancers

Status

Study Completed

Cancer Type(s)

Study Contact

Publications

A Phase II Trial of Gefitinib (Iressa) in Patients With Chemosensitive and Chemorefractory Relapsed Neuroendocrine Cancers

Trial Locations

All sites in which the trial HCRN-LUN02-29 being conducted in.

No data was found